FindTrial
Sign In

Influence of strengthened hemoperfusion uniting continuous venovenous hemofiltration on prognosis of patients with acute paraquat poisoning

Influence of strengthened hemoperfusion uniting continuous venovenous hemofiltration on prognosis of patients with acute paraquat poisoning

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018636
Enrollment
Unknown
Registered
2018-09-30
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute paraquat poisoning

Interventions

Case series:strengthened hemoperfusion uniting continuous venovenous hemofiltration

Sponsors

The 2nd Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged at least 14 years old; 2. Patients have clear contact history of paraquat; 3. Patients see a doctor in Emergency Department of the Second Affiliated Hospital of Kunming Medical University within 48 hours after poisoning; 4. Patients have symptom of paraquat poisoning.

Exclusion criteria

Exclusion criteria: 1. Mixed poisoning; 2. Pregnancy; 3. Patients have chronic lung disease, chronic liver and kidney function impairment; 4. Loss of follow-up visit.

Design outcomes

Primary

MeasureTime frame
all-cause mortalityin the 90th day after poisoning;—

Secondary

MeasureTime frame
all-cause mortality in the 15th day after poisoning;percentage of patients with respiratory failure;percentage of patients using mechanical ventilation;—

Countries

China

Contacts

Public ContactFang Li

The 2nd Affiliated Hospital of Kunming Medical University

fangli1390886@163.com+86 18487190523

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026